AgingResearch.News
Brain agingModel organisms

Alpha-synuclein impairs triglyceride metabolism and mitochondrial structure in aging nematodes

Restoring lipid balance through medium-chain triglycerides or fatty acid inhibition protected worms from alpha-synuclein-driven movement deficits.

EMBO Reports

In the nematode Caenorhabditis elegans, researchers found that alpha-synuclein progressively alters lipid metabolism during aging. The protein reduces total triacylglycerols and disrupts the structures of both lipid droplets and mitochondria. These structural defects depend on the ability of alpha-synuclein to bind lipids and condense into inclusions. While reducing triacylglycerols, alpha-synuclein also proportionally increases long-chain unsaturated fatty acids. Modifying these lipid pathways countered the damage in worms. Genetically blocking the synthesis of long-chain unsaturated fatty acids alleviated alpha-synuclein-induced loss of motility. Supplementing the nematodes with medium-chain triglycerides also improved toxicity phenotypes. Noting that Parkinson's disease cohorts show lower plasma triacylglycerols, the researchers conclude that alpha-synuclein condensation impairs lipid balance to drive cellular toxicity.

Why it matters

The findings link protein aggregation directly to lipid depletion and mitochondrial damage in aging organisms. Understanding this metabolic disruption highlights medium-chain triglyceride supplementation as a potential therapeutic approach for age-related synucleinopathies.

Caveats

Most mechanistic findings rely on the invertebrate Caenorhabditis elegans, meaning the results may not fully translate to human neurobiology. The study also does not establish whether dietary medium-chain triglycerides are effective in human clinical trials.

The paper

Condensate-driven triglyceride reduction links α-synuclein to mitochondrial dysfunction

Zhang T, Herron-Bedoya A, Eugenia Goya M et al.

EMBO Reports · 29 Sep 2026

See all